The State of Nevada has announced that it will receive a $45-million settlement from McKinsey & Company. The consulting firm is alleged to have played a key role in assisting OxyContin maker Purdue Pharma and other pharmaceutical companies in spreading the use of opioids in the United States. By opting out of the national settlement, the Nevada attorneys general were able to receive three times more than most states in the McKinsey & Company Nevada settlement.
Opioids are a highly addictive type of drug that can lead to serious mental and physical health problems. In addition to ravaging the body and mind of the user, opioid abuse can lead to neonatal abstinence syndrome (NAS), which can cause grave health issues in newborns.
McKinsey & Company Nevada Settlement Reflects How Hard the State Was Hit
Purdue Pharma has been working with McKinsey & Company for more than a decade. Attorneys general from across America claim that it played a key role in the manufacturing, marketing, and selling of opioids. By being able to manipulate the product chain from the manufacturer to the prescribing doctor to the patient, the company is considered a major contributor to America’s opioid crisis.
McKinsey & Company originally settled with 47 states for a total of $573-million. However, Nevada felt that the amount was insufficient for the damage opioids have done to the state. The McKinsey & Company Nevada settlement noted:
Nevada has been uniquely impacted by the opioid crisis because it has been, and continues to be, one of the hardest hit states by the opioid epidemic. The opioid crisis has resulted in thousands of deaths of Nevadans and has imposed an enormous burden on state resources needed to help thousands of addicted Nevadans. This settlement comes at a time that Nevada needs an influx in funds to continue its work addressing the opioids epidemic, which is particularly important in light of the pandemic that has seen a resurgence in opioid-related deaths in Nevada.
Nevada Attorney General Aaron Ford added:
The devastation caused by the opioid epidemic affects us all. It’s felt by every mother and father who has lost a child. It’s felt by siblings who have lost a sister or brother. And it’s felt by friends and colleagues who lost one of their own.
Contact a Neonatal Abstinence Syndrome Lawyer
As AG Ford mentioned, opioid addiction affects entire families, not just the person taking the drug. Neonatal abstinence syndrome is one example of how devastating opioid abuse can be. Companies like McKinsey & Co helped make OxyContin and other opioids inappropriately popular, which has led to a national health crisis.
If a child in your family has suffered from neonatal abstinence syndrome then contact Lerner and Rowe for a free consultation. We will carefully review your claim to help determine if you may be entitled to compensation for being a victim of an intricate pharmaceutical scheme.
The legal team at Lerner and Rowe is available to help you 24/7. Let us help you fight back against the deceptive companies responsible for Nevada’s opioid crisis. You can reach us by phone at 702-877-1500 or you can submit your case information online with a LiveChat representative.
Our team is confident that you’ll quickly find out why Lerner and Rowe’s legal team is one of the most trusted names in Nevada with a long history of getting our clients results.
The information on this blog is for general information purposes only. Nothing herein should be taken as legal advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship.